Amplifications and mutations of the EGFR gene, particularly within the extracellular domain, result in constitutive activation of downstream signaling pathways such as PI3K/AKT and MAPK, thereby promoting tumor cell proliferation, invasion, and angiogenesis [61]. This evidence concerns the gene EGFR and neoplasm.